Sun Pharma arm launches plaque psoriasis treatment drug in Japan

In a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection 100 mg Syringe in Japan for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies".

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33SoYbr
via IFTTT